RAPT Therapeutics Inc (RAPT) — Strategic Asset Allocation Index
RAPT Therapeutics Inc (RAPT) has a Strategic Asset Allocation Index of 1.5% as of June 2023. Strategic assets (PP&E of $2.96 Million plus long-term investments of $-) total $2.96 Million, measured against net assets of $199.68 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. For live market cap and overall valuation, see market cap of RAPT Therapeutics Inc.
SAAI
Strategic Assets
PP&E
Net Assets
RAPT Therapeutics Inc Strategic Asset Allocation Index (2018–2022)
This chart shows how RAPT Therapeutics Inc's Strategic Asset Allocation Index has evolved across 5 annual periods from 2018 to 2022. As of June 2023, the index stands at 1.5%, representing strategic assets of $2.96 Million against net assets of $199.68 Million USD. See RAPT Therapeutics Inc (RAPT) balance sheet quality index to measure how much of total assets are equity-financed.
Annual Strategic Asset Allocation Index for RAPT Therapeutics Inc (2018–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for RAPT Therapeutics Inc from 2018 to 2022, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. Also explore RAPT year-over-year net asset growth to track the company's year-over-year net asset growth rate.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 1.0% | $2.54 Million | $2.54 Million | $- | $245.17 Million | ▼ -0.4 pp |
| 2021 | 1.5% | $2.74 Million | $2.74 Million | $- | $186.38 Million | ▼ -1.4 pp |
| 2020 | 2.9% | $2.98 Million | $2.98 Million | $- | $104.18 Million | ▼ -2.2 pp |
| 2019 | 5.1% | $3.71 Million | $3.71 Million | $- | $73.12 Million | ▼ -1.4 pp |
| 2018 | 6.5% | $4.16 Million | $4.16 Million | $- | $64.00 Million | — |